ORMP:NASDAQ
Oramed Pharmaceuticals, Inc.
$3.69
arrow_downward
-0.54%(-0.020) 1D
Jun 8, 3:15:12 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORMP...
Open
$3.68
High
$3.78
Low
$3.64
Mkt. cap
151.02M
Avg. vol.
207.66K
Volume
90.58K
P/E ratio
1.42
52-wk high
$5.01
52-wk low
$1.98
EPS
$2.60
Beta
1.26
Shares outstanding
40.93M
No. of employees
13
Open
$3.68
High
$3.78
Low
$3.64
Mkt. cap
151.02M
Avg. vol.
207.66K
Volume
90.58K
P/E ratio
1.42
52-wk high
$5.01
52-wk low
$1.98
EPS
$2.60
Beta
1.26
Shares outstanding
40.93M
No. of employees
13
News stories
From sources across the web
The Motley Fool
·
14 minutes ago
The One-Two Punch That Could Be Disastrous for the S&P 500 This Year
富途牛牛
·
17 minutes ago
Dow Jones Top Company Headlines at 3 PM ET: Apple Unveils 'Siri AI' at Developer Event, Seeking a New Foothold in AI | Amazon ...
Profile
Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange. Wikipedia
About Oramed Pharmaceuticals, Inc.
AI content may include mistakes. Learn more